Anterix (ATEX) CMO Heather Martin receives RSU and stock option grants
Rhea-AI Filing Summary
Anterix Inc. Chief Marketing Officer and Chief of Staff Heather Martin received new equity compensation in the form of restricted stock units and stock options. She was granted 3,694 RSUs representing the right to receive the same number of Anterix common shares, bringing her direct common stock holdings to 38,272 shares after the award.
She was also granted stock options for 17,453 shares of common stock at an exercise price of $60.90 per share, expiring on May 20, 2036. Both the RSUs and the options vest over three years, with one-third vesting on May 20, 2027 and the remaining two-thirds vesting in equal quarterly installments on specified dates through May 20, 2029. These are compensation-related grants, not open-market purchases or sales.
Positive
- None.
Negative
- None.
Insights
Routine equity grants increase the CMO’s long-term incentive exposure.
The filing shows Heather Martin receiving 3,694 restricted stock units and options on 17,453 shares at an exercise price of $60.90 per share. These awards are standard compensation tools that link a senior executive’s upside to future share performance.
The RSUs and options vest over three years, with one-third vesting on May 20, 2027 and the rest quarterly through May 20, 2029. There are no open-market buys or sales, so this primarily updates her incentive alignment rather than signaling a change in her view of the stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 17,453 | $0.00 | -- |
| Grant/Award | Common Stock | 3,694 | $0.00 | -- |
Footnotes (1)
- Represents the issuance of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer's Common Stock. The RSUs vest over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029. The option shares vest and become exercisable over three years, with 1/3 vesting on May 20, 2027, and 1/12 vesting quarterly thereafter on August 10, November 10, February 10, and May 20 of each year through May 20, 2029.